ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » South Carolina » Pulmonary Disease

Top Pulmonary Disease Prescribers in South Carolina

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
IFEDORIA AFULUKWE MD

Pulmonary Disease

23,043

$1.26M

921
528 are 65+

13%
patients receiving schedule two controlled substances

Avg: 2%

20%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 58%

$55
Average prescription price

Avg: $183

NICHOLAS SANITO D.O.

Pulmonary Disease

6,987

$1.29M

439
313 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

6%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

49%
prescriptions for brand name drugs

Avg: 58%

$185
Average prescription price

Avg: $183

ABBAS MANSOUR M.D.

Pulmonary Disease

6,228

$771K

701
413 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

58%
prescriptions for brand name drugs

Avg: 58%

$124
Average prescription price

Avg: $183

EDDIE WILLIAMS MD

Pulmonary Disease

6,017

$562K

241
206 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

7%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 58%

$93
Average prescription price

Avg: $183

MIROSLAV ZOTOVIC M.D.

Pulmonary Disease

4,886

$1.03M

423
313 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

60%
prescriptions for brand name drugs

Avg: 58%

$210
Average prescription price

Avg: $183

CHARLES THOMPSON MD

Pulmonary Disease

4,143

$1.22M

383
243 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

4%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

55%
prescriptions for brand name drugs

Avg: 58%

$294
Average prescription price

Avg: $183

ARUN ADLAKHA M.D.

Pulmonary Disease

3,788

$774K

444
277 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

5%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

52%
prescriptions for brand name drugs

Avg: 58%

$204
Average prescription price

Avg: $183

RAVI CHANDRAN M.D.

Pulmonary Disease

3,603

$598K

516
349 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

68%
prescriptions for brand name drugs

Avg: 58%

$166
Average prescription price

Avg: $183

MICHAEL SPANDORFER MD

Pulmonary Disease

3,578

$799K

401
259 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

3%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

63%
prescriptions for brand name drugs

Avg: 58%

$223
Average prescription price

Avg: $183

JOSEPH BOSCIA MD

Pulmonary Disease

3,435

$598K

526
344 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

67%
prescriptions for brand name drugs

Avg: 58%

$174
Average prescription price

Avg: $183

MICHAEL MARSHALL MD

Pulmonary Disease

3,180

$644K

389
308 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

67%
prescriptions for brand name drugs

Avg: 58%

$203
Average prescription price

Avg: $183

DAVID ERB MD

Pulmonary Disease

2,818

$451K

350
224 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

83%
prescriptions for brand name drugs

Avg: 58%

$160
Average prescription price

Avg: $183

THOMAS CHANDLER MD

Pulmonary Disease

2,725

$593K

373
297 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

76%
prescriptions for brand name drugs

Avg: 58%

$218
Average prescription price

Avg: $183

WILLIAM WALKER MD

Pulmonary Disease

2,602

$311K

264
198 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

5%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 58%

$120
Average prescription price

Avg: $183

CHARLES FOGARTY MD

Pulmonary Disease

2,579

$260K

194
135 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

26%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

46%
prescriptions for brand name drugs

Avg: 58%

$101
Average prescription price

Avg: $183

JAIRAJ PRASHAD MD

Pulmonary Disease

2,434

$158K

122
98 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

19%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 58%

$65
Average prescription price

Avg: $183

MARY VOGT MD

Pulmonary Disease

2,427

$344K

273
193 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

60%
prescriptions for brand name drugs

Avg: 58%

$142
Average prescription price

Avg: $183

MARK MAYSON MD

Pulmonary Disease

1,897

$426K

236
185 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

5%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

54%
prescriptions for brand name drugs

Avg: 58%

$224
Average prescription price

Avg: $183

GREGORY FELDMAN MD

Pulmonary Disease

1,859

$335K

354
231 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

69%
prescriptions for brand name drugs

Avg: 58%

$180
Average prescription price

Avg: $183

SHYAM YALLAPRAGADA MD

Pulmonary Disease

1,784

$160K

131
92 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

11%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

46%
prescriptions for brand name drugs

Avg: 58%

$90
Average prescription price

Avg: $183

EDWARD KNIGHT MD

Pulmonary Disease

1,768

$160K

264
195 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

5%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

43%
prescriptions for brand name drugs

Avg: 58%

$91
Average prescription price

Avg: $183

CARLTON CAUTHEN M.D.

Pulmonary Disease

1,766

$489K

257
193 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

54%
prescriptions for brand name drugs

Avg: 58%

$277
Average prescription price

Avg: $183

CHARLES CREAGH M.D.

Pulmonary Disease

1,749

$228K

268
194 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

64%
prescriptions for brand name drugs

Avg: 58%

$130
Average prescription price

Avg: $183

VINOD JONA M.D.

Pulmonary Disease

1,672

$353K

270
205 are 65+

8%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

47%
prescriptions for brand name drugs

Avg: 58%

$211
Average prescription price

Avg: $183

Z KHIANGTE M.D.

Pulmonary Disease

1,672

$436K

241
151 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

67%
prescriptions for brand name drugs

Avg: 58%

$261
Average prescription price

Avg: $183

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank